论文部分内容阅读
α 干扰素 (ＩＦＮ α)可以延长慢性粒细胞白血病 (ＣＭＬ)的生存期 ,但一些病人对其无反应或反应不持久。为了改善治疗效果 ,ＩＦＮ α常与其他治疗联用 ,但到目前为止 ,只有ＩＦＮ α联合低剂量阿糖胞苷 (Ａｒａ Ｃ)可以增加反应率及延长生存期。本文为 53 8例Ｐｈ+ＣＭＬ患?
Interferon-alpha (IFN-alpha) prolongs the survival of chronic myeloid leukemia (CML), but some patients do not respond or respond to it. In order to improve the therapeutic effect, IFNα often associated with other therapies, but so far only IFNα combined with low doses of cytarabine (Ara C) can increase the response rate and prolong survival. 538 Ph + CML patients in this article?